GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Cerebroprotein hydrolysate for Injection (30mg)
B. Cerebroprotein hydrolysate for Injection (60mg)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Cerebroprotein hydrolysate for Injection (30mg)
Composition:
Each vial contains:
Cerebroprotein
hydrolysate………1050mg (approx)
Equivalent to Nitrogen……30mg
Excipients………………………q.s.
One Ampoule contains:
Sterile Water for Injection USP…………5ml

B. Cerebroprotein hydrolysate for Injection (60mg)
Composition:
Each vial contains:
Cerebroprotein
hydrolysate………2100mg (approx)
Equivalent to Nitrogen……60mg
Excipients………………………q.s.
One Ampoule contains:
Sterile Water for Injection USP…………10ml


THERAPEUTIC INDICATIONS:

Cerebroprotein Hydrolysate is used in the treatment of stroke, head injury and Alzheimer's disease. Cerebroprotein Hydrolysate is a nerve repairing medicine. It works on the brain by repairing the nerve cells and improves their survival.

DIRECTION OF USE:

Reconstituted solution: From a microbial point of view, the product should be used immediately.
If not use immediately, in the use storage time & conditions prior to use are the responsibility of the user, unless reconstitution has taken place in controlled & validated aseptic conditions.
For method of reconstitution, storage, administration, dosage & indications: Refer to the enclosed package insert.

CAUTION & WARNING:

CAUTION: Do not use the injection if the contents are not clear or contains visible particulate matter after reconstitution.
FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE
Warning: If any foreign particle is visible in the vial after dissolving the contents, please do not use the solution & return for the replacement.
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

Storage: Store below 25°C.
Do not freeze.
If not use immediately, the reconstituted solution can be stored at up to 25°C for up to 24 hours.
Keep all medicines out of reach of children.
Dosage: As directed by Physician.
Do not skip any doses and finish the full course of treatment even if you feel better.

Cerebroprotein hydrolysate for Injection 60mg Technical Specification:

Product Name:Cerebroprotein Hydrolysate for Injection 60mg
Brand Name:Ceretaj
Strength:30mg, 60mg
Dosage Form:Lyophilized
Dry Powder Injection (Sterile) *Preservative Free
Packing:1 Vial + 1 Ampule + WFI Tray
Route of Administration:For I.V. infusion only
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:Anti-Alzheimer’s
Indication: Cerebroprotein Hydrolysate is used in the treatment of stroke, head injury and Alzheimer’s disease. Cerebroprotein Hydrolysate is a nerve repairing medicine. It works on the brain by repairing the nerve cells and improves their survival.
Storage:Store below 25°C. Do not freeze. If not use immediately, the reconstituted solution can be stored at up to 25°C for up to 24 hours.

GENERIC NAME OF MEDICINAL PRODUCT:

  • Cerebroprotein hydrolysate for Injection (60mg)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Cerebroprotein hydrolysate for Injection (60mg)
    Composition:
    a.Each vial contains:
    Cerebroprotein
    hydrolysate………2100mg (approx)
    Equivalent to Nitrogen……60mg
    Excipients………………………q.s.
    b.One Ampoule contains:
    Sterile Water for Injection USP…………10ml

 THERAPEUTIC INDICATIONS:

Cerebroprotein Hydrolysate is used in the treatment of stroke, head injury and Alzheimer’s disease. Cerebroprotein Hydrolysate is a nerve repairing medicine. It works on the brain by repairing the nerve cells and improves their survival. Cerebroprotein hydrosylate is also indicated for “Neuronal differentiation” and protection against ischaemic and neurotoxic lesions.

DIRECTION OF USE:

Reconstituted solution: From a microbial point of view, the product should be used immediately.

If not use immediately, in the use storage time & conditions prior to use are the responsibility of the user, unless reconstitution has taken place in controlled & validated aseptic conditions.

For method of reconstitution, storage, administration, dosage & indications: Refer to the enclosed package insert.

CAUTION & WARNING:

CAUTION: Do not use the injection if the contents are not clear or contains visible particulate matter after reconstitution.

FLIP-OFF SEAL IS PROVIDED FOR TAMPER EVIDENCE

Warning: If any foreign particle is visible in the vial after dissolving the contents, please do not use the solution & return for the replacement.

WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

Storage: Store below 25°C.
Do not freeze.
If not use immediately, the reconstituted solution can be stored at up to 25°C for up to 24 hours.

Keep all medicines out of reach of children.

Dosage: As directed by Physician.
Do not skip any doses and finish the full course of treatment even if you feel better.

Why Taj Pharmaceuticals?

Taj Pharmaceuticals stands out as the trusted provider for Cerebroprotein Hydrolysate for Injection, backed by a legacy of pharmaceutical excellence. With a relentless commitment to quality, Taj Pharmaceuticals ensures that each vial of Cerebroprotein Hydrolysate meets rigorous safety and efficacy standards. Their dedication to innovation and research propels them forward in the pharmaceutical industry, where they continually invest in cutting-edge technologies. Taj Pharmaceuticals boasts a global presence, making this essential medication accessible worldwide while adhering to strict regulatory compliance and holding esteemed certifications. Their patient-centric approach places patient safety at the forefront, offering flexibility in packaging and competitive pricing to improve healthcare on a global scale. Taj Pharmaceuticals is the preferred choice for healthcare professionals and patients alike, seeking the highest standard of care for Cerebroprotein Hydrolysate. Trust Taj Pharmaceuticals for your pharmaceutical needs.

What is Cerebroprotein hydrolysate for Injection and its uses:

Cerebroprotein Hydrolysate for Injection is a medication containing a hydrolysate of brain proteins, primarily known for its potential neuroprotective and neurotrophic properties. This medication finds application in several areas within the realm of neurology and cognitive health.

In the context of neurological disorders, Cerebroprotein Hydrolysate is often prescribed to individuals dealing with conditions like Alzheimer’s disease, Parkinson’s disease, and stroke. The medication’s neurotrophic properties are believed to play a role in supporting the growth and maintenance of neurons in the brain, which may help slow the progression of these disorders.

Additionally, it is used to address cognitive impairment and memory deficits, especially in elderly individuals. Some healthcare providers consider Cerebroprotein Hydrolysate as a potential aid to cognitive function and memory retention, particularly in aging populations.

In cases of neurological injury and recovery, such as traumatic brain injuries or post-surgical rehabilitation, Cerebroprotein Hydrolysate may be employed to aid in neurological recovery. It is thought to support the brain’s healing processes during the critical phases of recuperation.

Furthermore, the medication is sometimes incorporated into the treatment plans of individuals with various forms of dementia, given its potential benefits for brain function and cognition. This application aims to alleviate the cognitive symptoms associated with these conditions.

Lastly, for addressing age-related cognitive decline, Cerebroprotein Hydrolysate may be considered to help mitigate the impact of cognitive changes that can occur with aging, such as declines in memory, concentration, and overall cognitive function in older adults.

It’s crucial to emphasize that the effectiveness of Cerebroprotein Hydrolysate remains a subject of ongoing research and clinical debate. As with any medication, its usage should be carefully considered and discussed with a healthcare provider, who can assess an individual’s specific medical condition, potential benefits, and any associated risks or side effects, in order to make informed treatment decisions.

How does Cerebroprotein hydrolysate for Injection Work:

Cerebroprotein Hydrolysate for Injection is a medication whose precise mechanism of action remains the subject of ongoing research and exploration. While not fully understood, its potential effects on the brain are of great interest in the field of neurology and cognitive health.

At its core, Cerebroprotein Hydrolysate is believed to exert its influence through several possible mechanisms. It is thought to possess neurotrophic properties, which means it may promote the growth, development, and maintenance of neurons in the brain. This could be particularly relevant in conditions characterized by neuronal damage or degeneration, such as neurodegenerative diseases like Alzheimer’s and Parkinson’s.

Additionally, it is considered to have neuroprotective effects, which may involve safeguarding neurons from damage and cell death caused by various factors, including oxidative stress, inflammation, and excitotoxicity. This potential neuroprotection holds promise for conditions involving brain injury or neurotoxicity.

Cerebroprotein Hydrolysate may also contribute to enhanced brain function. While the specifics of this potential enhancement are still being studied, it may encompass improvements in cognitive abilities like memory, learning, and concentration, which can be significant for individuals facing cognitive challenges.

Furthermore, some researchers propose that the medication might modulate neurotransmitters in the brain. These chemical messengers play a pivotal role in brain communication, potentially affecting mood, cognition, and behavior.

Finally, Cerebroprotein Hydrolysate could have anti-inflammatory properties, which could be valuable in mitigating inflammation-related damage in the brain, a factor in various neurological conditions.

It’s important to emphasize that while these potential mechanisms are intriguing, the full scope of Cerebroprotein Hydrolysate’s actions on the brain is still under investigation. Clinical studies continue to assess its efficacy and safety in diverse medical contexts. As such, its use should be guided by healthcare professionals who can evaluate its suitability for an individual’s specific condition and needs.

Benefits of Cerebroprotein Hydrolysate for Injection:

Cerebroprotein Hydrolysate offers potential advantages in the realm of neurology and cognitive health. Its most notable benefit lies in its hypothesized neuroprotective effect, which may shield neurons from harm caused by factors like oxidative stress, inflammation, and excitotoxicity. This property holds promise in situations involving brain injury and neurotoxicity. Additionally, Cerebroprotein Hydrolysate is believed to have neurotrophic properties, supporting the growth and maintenance of brain neurons, which could be particularly beneficial in neurodegenerative diseases marked by neuronal degeneration.

For individuals grappling with cognitive challenges, this medication might bring about enhanced cognitive function, including improvements in memory, learning, and concentration. Such enhancements can significantly impact the quality of life for those facing cognitive difficulties. Moreover, Cerebroprotein Hydrolysate may influence neurotransmitter levels and activity, affecting mood and cognition, and could offer anti-inflammatory effects to mitigate brain inflammation, which is relevant in various neurological conditions.

Side Effects of Cerebroprotein Hydrolysate for Injection:

Despite its potential benefits, Cerebroprotein Hydrolysate may come with certain side effects to consider. Allergic reactions, though uncommon, are possible and can range from mild skin reactions to severe anaphylactic responses, warranting immediate medical attention. Some individuals may experience gastrointestinal disturbances, such as nausea, vomiting, diarrhea, or abdominal discomfort.

Additionally, localized pain, redness, or swelling at the injection site can occur due to its method of administration. As with any medication, there is a potential for drug interactions with other medications an individual may be taking, underlining the importance of full disclosure to healthcare providers to avoid adverse interactions. Lastly, the use of Cerebroprotein Hydrolysate is based on evolving research, and its clinical data remain limited, emphasizing the need for caution and medical supervision when considering its use, particularly for off-label purposes.

In light of these potential benefits and side effects, individuals should engage in open discussions with healthcare providers when considering Cerebroprotein Hydrolysate. Medical professionals can assess its suitability for specific medical conditions, weigh the potential advantages against the associated risks, and ensure careful monitoring during treatment to optimize its use.

Frequently Asked Questions About Cerebroprotein hydrolysate for Injection:

  1. What is Cerebroprotein Hydrolysate for Injection used for?

Cerebroprotein Hydrolysate for Injection is used primarily in the field of neurology and cognitive health. It is employed for its potential neuroprotective, neurotrophic, and cognitive-enhancing properties and is considered in various conditions such as neurodegenerative diseases, brain injuries, and cognitive impairments.

  1. How does Cerebroprotein Hydrolysate work in the brain?

The exact mechanism of action is not fully understood, but it is believed to exert neurotrophic and neuroprotective effects. It may support the growth, maintenance, and protection of neurons in the brain. Additionally, it may influence neurotransmitter levels and have anti-inflammatory properties.

  1. Are there any common side effects of Cerebroprotein Hydrolysate for Injection?

Common side effects may include mild gastrointestinal disturbances like nausea and abdominal discomfort, pain or swelling at the injection site, and in some cases, allergic reactions. Severe allergic reactions are rare but can occur.

  1. Can Cerebroprotein Hydrolysate improve memory and cognitive function?

Some individuals may experience improvements in memory, learning, and concentration with the use of Cerebroprotein Hydrolysate. However, the extent and specific effects on cognitive function can vary from person to person.

  1. Is Cerebroprotein Hydrolysate safe for long-term use?

The long-term safety of Cerebroprotein Hydrolysate is still being studied, and its use should be monitored by healthcare professionals. The duration of treatment and its suitability for long-term use depend on individual medical conditions and treatment goals.

  1. Can I use Cerebroprotein Hydrolysate along with other medications?

Cerebroprotein Hydrolysate has the potential to interact with other medications. It is essential to inform your healthcare provider of all medications and supplements you are taking to assess potential interactions and ensure safe co-administration.

  1. Are there specific medical conditions for which Cerebroprotein Hydrolysate is recommended?

Cerebroprotein Hydrolysate may be considered for conditions such as neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s), cognitive impairments, and brain injuries. However, its use should be determined on a case-by-case basis by healthcare professionals.

  1. Can Cerebroprotein Hydrolysate be used in pediatric patients or the elderly?

The use of Cerebroprotein Hydrolysate in specific age groups, such as pediatric or elderly patients, should be discussed with a healthcare provider, who can evaluate its appropriateness based on individual medical needs and potential benefits and risks.

  1. Is Cerebroprotein Hydrolysate available over-the-counter (OTC)?

Cerebroprotein Hydrolysate is typically not available over-the-counter. It is a prescription medication, and its use should be supervised by a healthcare professional who can assess your specific medical condition and determine the appropriate treatment plan.

  1. Are there ongoing clinical trials or research studies involving Cerebroprotein Hydrolysate?

Research on Cerebroprotein Hydrolysate is ongoing, with clinical trials and studies exploring its efficacy, safety, and potential applications. Individuals interested in participating in such trials should consult with healthcare providers or research institutions for more information.

Cerebroprotein Hydrolysate for Injection Exporters; We can cater to export business queries from the following geographies. We are exporting our Cerebroprotein Hydrolysate for Injection product in Following Countries:

Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine

GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, and Iraq.

African Countries: Nigeria, Tanzania, Sudan, Zambia, Benin, Angola, Liberia

Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam

Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius

Cerebroprotein Hydrolysate for Injection Regulatory Documents:

  • Certificate of Analysis (COA)
  • Method of Analysis (MOA)
  • Stability Data (Accelerated stability / Long-term stability / Zone 4b)
  • CTD Dossier / ACTD Dossiers / eCTD Dossiers
  • Certificate of Pharmaceuticals Product (COPP)
  • Free Sale Certificate (FSC)
Contact the most reliable manufacturer of Cerebroprotein Hydrolysate for Injection, Taj Pharmaceuticals Limited, to get bulk quantities at a reasonable price.

To Place Orders:

Direct line: +91 8448 444 095 / WhatsApp +91 74 0000 9975 / 74 0000 9976
E-Mail: info@tajpharma.com
Toll free: 1-800-222-434 / Toll free: 1-800-222-825
General EPA BX: +91 22 2637 4592 / +91 22 2637 4593
Fax No: +91 22 2634 1274